Registry of patients with acute cardiovascular diseases in Naples

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the current epidemiology, management, and clinical outcomes of patients with acute cardiovascular diseases admitted to the Intensive Cardiac Care Unit (ICCU) at the University of Naples Federico II. It will collect demographic, clinical, procedural, therapeutic, and outcome data from patients who provide informed consent. The study will follow patients during their hospital stay and at subsequent follow-ups to assess clinical outcomes, which will be adjudicated by an independent committee. The data will be anonymized and managed using a secure electronic data capture system.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Acute cardiovascular disease admitted at our ICCU
2. Age ≥18 years;
3. Written informed consent.

Exclusion Criteria:

1\) Patients not providing consent to data collection

Where it's running

• Department of Advanced Biomedical Sciences, University Federico II of Naples
  Naples, Italy Recruiting

Study contacts

• Principal investigator: Giuseppe Gargiulo, MD, PhD — Department of Advanced Biomedical Sciences
• Study coordinator: Giuseppe Gargiulo, MD, PhD
• Email: giuseppe.gargiulo1@unina.it
• Phone: +39-7462253

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Characterizing phenotypes of acute heart failure

  This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg · NCT07508891

• Identifying triggers and progression of heart failure

  This study looks at patients with heart failure to see what causes it and how it gets worse, while also testing if digoxin can help those whose heart failure is triggered by fast heartbeats.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT04000061

• Factors Influencing Outcomes in ECMO and Impella Patients

  This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.

  Recruiting Gottsegen National Cardiovascular Institute · Budapest · NCT07885618

• Common femoral vein-to-artery diameter ratio to detect elevated LVEDP

  Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.

  Recruiting Burapha University · Chon Buri · NCT07866859

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock

  This study tests whether an extracorporeal ventricular assist device can safely provide short-term heart support and help patients with cardiogenic shock or trouble weaning from bypass.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07769528

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.